A biotechnology company whose shares more than doubled after it said that it had obtained regulatory clearance for the world’s first brain cancer vaccine is facing a class action lawsuit in the United States alleging that it misled investors.
Link to Article
Biotech firm sued over brain cancer vaccine claim - The Times 28th August 2007
Saturday, August 25, 2007
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment